Founded in 1991 by Dr Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, our company soon moved on to true biotech research, including the research and development of vaccines, oncology. New drug delivery technologies etc. The first major success came when we sold our genetically engineered recombinant Hepatitis B vaccine technology along with our novel and patented process in 1999 to the Serum Institute, Pune.

Today our company is listed on the Bombay Stock Exchange (BSE: TRABI – 526139) and has close to three decades of knowledge, experience and success behind it. We have an impressive product and technology portfolio covering Oncology, Oral Drug Delivery and Biogenerics. We passionately strive to bring these technologies to improve the lives of those suffering from Cancer through our novel drug innovations or to improve the acceptability of people for their betterment through our novel oral drug delivery technologies in cases of vaccines or cancer drugs hitherto administered through injections.

At Transgene, we are committed to maximizing our pipeline’s potential and bringing meaningful innovation to global health through strategic partnerships and collaborations.

We invite you to join us.